Nitrogen

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for use in specific medical situations where the administration of Nitrogen is deemed necessary. It is essential that this drug be administered only by or under the supervision of a licensed practitioner who possesses experience in the use and administration of Nitrogen. The practitioner must be knowledgeable about the indications, effects, dosages, methods, frequency, and duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Limitations of use include the potential hazards associated with Nitrogen administration, which necessitate careful consideration and oversight by qualified healthcare professionals. There are no reported teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For administration, this product is intended for use only by or under the supervision of a licensed practitioner who is experienced in the use and administration of Nitrogen.

The route of administration is via respiratory inhalation. Healthcare professionals should ensure that the patient is properly positioned and that the inhalation device is functioning correctly prior to use. It is essential to monitor the patient closely during administration to assess for any adverse reactions or complications.

Contraindications

There are no specific contraindications identified for this product. However, it is essential to adhere to the following precautions to ensure safe handling and use:

• Handling should only occur after all safety precautions have been thoroughly read and understood.

• The product must be used and stored exclusively outdoors or in a well-ventilated area to minimize exposure risks.

• Connections should not be altered or forced, as this may compromise safety and functionality.

Warnings and Precautions

Administration of Nitrogen may pose significant hazards and is contraindicated in certain situations. It is crucial to note that this product contains gas under pressure, which may explode if heated. Additionally, it can displace oxygen, leading to rapid suffocation. The presence of refrigerated gas also raises concerns, as it may cause cryogenic burns or injuries and further displace oxygen.

For safe use, Nitrogen should only be administered by or under the supervision of a licensed practitioner who possesses experience in its use and administration. This practitioner must be well-versed in the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions. Prior to handling Nitrogen, all safety precautions must be thoroughly read and understood.

It is imperative to use and store Nitrogen exclusively outdoors or in a well-ventilated area. A backflow preventive device should be employed in the piping to mitigate risks. Equipment used must be rated for cylinder pressure, and the valve should be closed after each use and when the cylinder is empty. Containers must be protected from sunlight, especially when ambient temperatures exceed 52 degrees Celsius (125 degrees Fahrenheit). Personal protective equipment, including cold insulating gloves, a face shield, and eye protection, should be worn at all times. Connections should not be changed or forced, and the container must always be kept in an upright position. The Safety Data Sheet (SDS) should be read and followed prior to use.

In the event of inhalation, it is critical to remove the affected individual to fresh air and ensure they are comfortable for breathing. Medical advice or attention should be sought immediately. If Nitrogen comes into contact with the skin, affected areas should be thawed with lukewarm water without rubbing, and immediate medical advice or attention is necessary.

For emergencies, individuals can contact 1-800-535-5053 for assistance.

Side Effects

Patients should be aware of the potential adverse reactions associated with the use of this product.

Serious adverse reactions include the risk of cryogenic burns or injury due to the presence of refrigerated gas. Additionally, there is a significant risk that the gas may displace oxygen, leading to rapid suffocation.

In the event of an adverse reaction, immediate first aid measures are crucial. If the gas is inhaled, it is important to remove the individual to fresh air and ensure they are comfortable for breathing. In cases where the gas comes into contact with the skin, it is advised to thaw any frosted areas with lukewarm water without rubbing the affected area. Immediate medical advice or attention should be sought in both scenarios to mitigate potential harm.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

The table below lists all NDC Code configurations of Nitrogen, the U.S. brand-name prescription product. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Administration of Nitrogen in pediatric patients may pose hazards or be contraindicated. It is essential that Nitrogen is used only by or under the supervision of a licensed practitioner who possesses experience in its use and administration. This practitioner should be well-versed in the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

There is no specific information available regarding the use of this medication during pregnancy, including safety concerns, dosage modifications, or special precautions. Healthcare professionals should consider the lack of data when prescribing this medication to pregnant patients. It is advisable to weigh the potential benefits against any unknown risks to fetal outcomes. Women of childbearing potential should be counseled on the importance of effective contraception during treatment and the need to inform their healthcare provider if they become pregnant or plan to become pregnant while on this medication.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or its effects during lactation. Healthcare professionals should consider the lack of data when advising lactating mothers about the use of this medication. It is recommended to weigh the potential benefits against any unknown risks to breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant and prepared for potential scenarios involving overdose.

Healthcare providers should be aware that the clinical presentation of an overdose may vary significantly depending on the substance involved and the individual patient’s characteristics. Symptoms may include, but are not limited to, altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of suspected overdosage, immediate assessment of the patient's condition is critical. Recommended actions include:

1. Assessment: Conduct a thorough evaluation of the patient's vital signs and clinical status.

2. Supportive Care: Initiate supportive measures as necessary, including airway management, oxygen supplementation, and intravenous fluids.

3. Decontamination: If appropriate and within a reasonable timeframe, consider gastrointestinal decontamination methods such as activated charcoal, provided the patient is alert and able to protect their airway.

4. Specific Antidotes: If a specific antidote is available for the substance involved, it should be administered according to established protocols.

Healthcare professionals are encouraged to consult local poison control centers or toxicology experts for guidance on management strategies tailored to the specific circumstances of the overdose. Continuous monitoring and supportive care are paramount until the patient stabilizes or further interventions are deemed necessary.

Documentation of the incident, including the substance involved, estimated dose, time of exposure, and clinical findings, is crucial for ongoing management and future reference.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No specific postmarketing experience details are available in the extracted data. As such, there are no reported adverse events or case reports to summarize.

Patient Counseling

Healthcare providers should advise patients that the administration of Nitrogen may pose hazards or be contraindicated. It is essential that Nitrogen is used only by or under the supervision of a licensed practitioner who is experienced in its use and administration. This practitioner should be familiar with the indications, effects, dosages, methods, frequency and duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Patients should be made aware of the warning that Nitrogen contains gas under pressure, which may explode if heated. Additionally, it may displace oxygen and cause rapid suffocation. Therefore, patients must not handle Nitrogen until they have read and understood all safety precautions. It is crucial to use and store Nitrogen only outdoors or in a well-ventilated area.

Healthcare providers should instruct patients to use a backflow preventive device in the piping and to utilize only equipment rated for cylinder pressure. Patients should be reminded to close the valve after each use and when the cylinder is empty. They should also protect the cylinder from sunlight when the ambient temperature exceeds 52 degrees Celsius (125 degrees Fahrenheit) and read and follow the Safety Data Sheet (SDS) prior to use.

In the event of inhalation, patients should be advised to remove themselves to fresh air and keep comfortable for breathing, seeking medical advice or attention as necessary. Furthermore, patients should be warned that Nitrogen contains refrigerated gas, which may cause cryogenic burns or injury, and can also displace oxygen, leading to rapid suffocation.

To prevent injury, patients should wear cold insulating gloves, a face shield, and eye protection. They must not change or force fit connections and should always keep the container in an upright position. In case of skin contact, patients should thaw frosted areas with lukewarm water without rubbing the affected area and seek immediate medical advice or attention.

Storage and Handling

The product is supplied in various configurations, with specific NDC numbers available for identification. It is essential to use and store the product exclusively outdoors or in a well-ventilated area to ensure safety and compliance with handling guidelines.

Storage conditions require protection from sunlight when the ambient temperature exceeds 52 degrees Celsius (125 degrees Fahrenheit). To maintain safety, the valve must be closed after each use and when the container is empty. The container should always be kept in an upright position to prevent leaks and ensure proper functioning.

When handling refrigerated liquid nitrogen, it is crucial to wear cold insulating gloves, a face shield, and eye protection. Prior to handling, all safety precautions must be thoroughly read and understood to mitigate risks. Additionally, a backflow preventive device should be utilized in the piping to enhance safety during use. It is imperative to avoid changing or forcing connections, as this may compromise the integrity of the system.

Additional Clinical Information

The route of administration for the product is via respiratory inhalation. Clinicians should be aware that the administration of Nitrogen may pose hazards or be contraindicated, and it should only be used under the supervision of a licensed practitioner experienced in its use. This practitioner must be knowledgeable about the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Patient counseling should emphasize the importance of safety measures, as the product contains gas under pressure and may explode if heated. It can also displace oxygen, leading to rapid suffocation. Patients should be instructed to handle the product only after thoroughly reading and understanding all safety precautions, to use and store it outdoors or in well-ventilated areas, and to employ backflow preventive devices in the piping. Additionally, they should close the valve after each use, protect the cylinder from sunlight when temperatures exceed 52 degrees C (125 degrees F), and consult the Safety Data Sheet (SDS) prior to use. In case of inhalation, individuals should be moved to fresh air and kept comfortable for breathing, and medical advice or attention should be sought.

FDA Insert (PDF)

This document is the official FDA-approved prescribing information for Nitrogen as submitted by Maine Oxy-Acetylene Supply Company. It includes detailed information about indications, dosage, contraindications, warnings, and clinical pharmacology.

View full prescribing information (PDF)